These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19108659)

  • 1. Orbitofrontal cortex volumes in medication naïve children with major depressive disorder: a magnetic resonance imaging study.
    Chen HH; Rosenberg DR; MacMaster FP; Easter PC; Caetano SC; Nicoletti M; Hatch JP; Nery FG; Soares JC
    J Child Adolesc Psychopharmacol; 2008 Dec; 18(6):551-6. PubMed ID: 19108659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder.
    Lacerda AL; Keshavan MS; Hardan AY; Yorbik O; Brambilla P; Sassi RB; Nicoletti M; Mallinger AG; Frank E; Kupfer DJ; Soares JC
    Biol Psychiatry; 2004 Feb; 55(4):353-8. PubMed ID: 14960287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression.
    Lavretsky H; Roybal DJ; Ballmaier M; Toga AW; Kumar A
    J Clin Psychiatry; 2005 Aug; 66(8):964-7. PubMed ID: 16086609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbitofrontal cortex gray matter volumes in bipolar disorder patients: a region-of-interest MRI study.
    Nery FG; Chen HH; Hatch JP; Nicoletti MA; Brambilla P; Sassi RB; Mallinger AG; Keshavan MS; Soares JC
    Bipolar Disord; 2009 Mar; 11(2):145-53. PubMed ID: 19267697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
    Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
    EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.
    Liu X; Kakeda S; Watanabe K; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umeno-Nakano W; Watanabe R; Ueda I; Moriya J; Nakamura J; Korogi Y
    Depress Anxiety; 2015 Sep; 32(9):702-8. PubMed ID: 26290363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-episode medication-naive major depressive disorder is associated with altered resting brain function in the affective network.
    Zhang X; Zhu X; Wang X; Zhu X; Zhong M; Yi J; Rao H; Yao S
    PLoS One; 2014; 9(1):e85241. PubMed ID: 24416367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms.
    Taylor WD; Macfall JR; Payne ME; McQuoid DR; Steffens DC; Provenzale JM; Krishnan KR
    Psychol Med; 2007 Dec; 37(12):1763-73. PubMed ID: 17335636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group.
    Schmaal L; Hibar DP; Sämann PG; Hall GB; Baune BT; Jahanshad N; Cheung JW; van Erp TGM; Bos D; Ikram MA; Vernooij MW; Niessen WJ; Tiemeier H; Hofman A; Wittfeld K; Grabe HJ; Janowitz D; Bülow R; Selonke M; Völzke H; Grotegerd D; Dannlowski U; Arolt V; Opel N; Heindel W; Kugel H; Hoehn D; Czisch M; Couvy-Duchesne B; Rentería ME; Strike LT; Wright MJ; Mills NT; de Zubicaray GI; McMahon KL; Medland SE; Martin NG; Gillespie NA; Goya-Maldonado R; Gruber O; Krämer B; Hatton SN; Lagopoulos J; Hickie IB; Frodl T; Carballedo A; Frey EM; van Velzen LS; Penninx BWJH; van Tol MJ; van der Wee NJ; Davey CG; Harrison BJ; Mwangi B; Cao B; Soares JC; Veer IM; Walter H; Schoepf D; Zurowski B; Konrad C; Schramm E; Normann C; Schnell K; Sacchet MD; Gotlib IH; MacQueen GM; Godlewska BR; Nickson T; McIntosh AM; Papmeyer M; Whalley HC; Hall J; Sussmann JE; Li M; Walter M; Aftanas L; Brack I; Bokhan NA; Thompson PM; Veltman DJ
    Mol Psychiatry; 2017 Jun; 22(6):900-909. PubMed ID: 27137745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grey matter volume abnormalities in the first depressive episode of medication-naïve adult individuals: a systematic review of voxel based morphometric studies.
    Amidfar M; Quevedo J; Z Réus G; Kim YK
    Int J Psychiatry Clin Pract; 2021 Nov; 25(4):407-420. PubMed ID: 33351672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal-subcortical volumetric deficits in single episode, medication-naïve depressed patients and the effects of 8 weeks fluoxetine treatment: a VBM-DARTEL study.
    Kong L; Wu F; Tang Y; Ren L; Kong D; Liu Y; Xu K; Wang F
    PLoS One; 2014; 9(1):e79055. PubMed ID: 24427263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter volume and rapid decision-making in major depressive disorder.
    Nakano M; Matsuo K; Nakashima M; Matsubara T; Harada K; Egashira K; Masaki H; Takahashi K; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():51-6. PubMed ID: 24076064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential brain structural alterations in major depressive disorder: A voxel-wise meta-analysis on first episode, medication-naive patients.
    Peng W; Chen Z; Yin L; Jia Z; Gong Q
    J Affect Disord; 2016 Jul; 199():114-23. PubMed ID: 27100056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical measurements of the orbitofrontal cortex in child and adolescent patients with bipolar disorder.
    Najt P; Nicoletti M; Chen HH; Hatch JP; Caetano SC; Sassi RB; Axelson D; Brambilla P; Keshavan MS; Ryan ND; Birmaher B; Soares JC
    Neurosci Lett; 2007 Feb; 413(3):183-6. PubMed ID: 17276600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional brain volume in depression and anxiety disorders.
    van Tol MJ; van der Wee NJ; van den Heuvel OA; Nielen MM; Demenescu LR; Aleman A; Renken R; van Buchem MA; Zitman FG; Veltman DJ
    Arch Gen Psychiatry; 2010 Oct; 67(10):1002-11. PubMed ID: 20921116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder.
    Kempton MJ; Salvador Z; Munafò MR; Geddes JR; Simmons A; Frangou S; Williams SC
    Arch Gen Psychiatry; 2011 Jul; 68(7):675-90. PubMed ID: 21727252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal volume abnormalities in treatment-naïve patients diagnosed with pediatric major depressive disorder.
    Matsuo K; Rosenberg DR; Easter PC; MacMaster FP; Chen HH; Nicoletti M; Caetano SC; Hatch JP; Soares JC
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):121-31. PubMed ID: 18439110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter volume reduction in orbitofrontal cortex correlated with plasma glial cell line-derived neurotrophic factor (GDNF) levels within major depressive disorder.
    Wu Y; Kong L; Yang A; Xin K; Lu Y; Yan X; Liu W; Zhu Y; Guo Y; Jiang X; Zhou Y; Sun Q; Tang Y; Wu F
    Neuroimage Clin; 2023; 37():103341. PubMed ID: 36739789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbitofrontal volume deficit in schizophrenia and thought disorder.
    Nakamura M; Nestor PG; Levitt JJ; Cohen AS; Kawashima T; Shenton ME; McCarley RW
    Brain; 2008 Jan; 131(Pt 1):180-95. PubMed ID: 18056163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parcellation of the human orbitofrontal cortex based on gray matter volume covariance.
    Liu H; Qin W; Qi H; Jiang T; Yu C
    Hum Brain Mapp; 2015 Feb; 36(2):538-48. PubMed ID: 25271073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.